Search Results - "Najib, Dally"

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing by Cohen, Yael C., Zada, Mor, Wang, Shuang-Yin, Bornstein, Chamutal, David, Eyal, Moshe, Adi, Li, Baoguo, Shlomi-Loubaton, Shir, Gatt, Moshe E., Gur, Chamutal, Lavi, Noa, Ganzel, Chezi, Luttwak, Efrat, Chubar, Evgeni, Rouvio, Ory, Vaxman, Iuliana, Pasvolsky, Oren, Ballan, Mouna, Tadmor, Tamar, Nemets, Anatoly, Jarchowcky-Dolberg, Osnat, Shvetz, Olga, Laiba, Meirav, Shpilberg, Ofer, Dally, Najib, Avivi, Irit, Weiner, Assaf, Amit, Ido

“…Multiple myeloma (MM) is a neoplastic plasma-cell disorder characterized by clonal proliferation of malignant plasma cells. Despite extensive research, disease…”
Get full text

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia by Benjamini, Ohad, Rokach, Lior, Itchaki, Gilad, Braester, Andrei, Shvidel, Lev, Goldschmidt, Neta, Shapira, Shirley, Dally, Najib, Avigdor, Abraham, Rahav, Galia, Lustig, Yaniv, Ben David, Shirley Shapiro, Fineman, Riva, Paz, Alona, Bairey, Osnat, Polliack, Aaron, Levy, Ilana, Tadmor, Tamar

“…Patients with chronic lymphocytic leukemia (CLL) have a suboptimal humoral response to vaccination. Recently, BNT162b2, an mRNA COVID-19 vaccine with a high…”
Get full text

The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis by Adir, Alper, Braester, Andrei, Natalia, Perelstein, Najib, Dally, Akria, Luiza, Suriu, Celia, Masad, Barhoum, Igor, Waksman

“…Introduction Acute appendicitis (AA) requires a prompt diagnosis. According to postoperative pathological results, a significant number of appendectomies are…”
Get full text

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy by Barki-Harrington, Liza, Baron-Epel, Orna, Shaulov, Adir, Akria, Luiza, Barshay, Yossef, Dally, Najib, Deshet, Dana, Inbar, Tsofia, Koren-Michowitz, Maya, Leiba, Merav, Moshe, Yakir, Shvidel, Lev, Tadmor, Tamar, Yagenah, Shai, Zektser, Miri, Preis, Meir, Hellman, Ilana, Yahalom, Vered, Aviv, Ariel

“…Background: One of the main obstacles of providing home-based palliative care to transfusion-dependent hematology patients is the lack of home transfusions…”
Get full text

Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center study by Simaan, Naaem, Metanis, Issa, Honig, Asaf, Hallevi, Hen, Filioglo, Andrei, Mendel, Rom, Barnea, Rani, Naftali, Jonathan, Auriel, Eitan, Aladdin, Shorooq, Orion, David, Dally, Najib, Leker, Ronen R, Molad, Jeremy

“…Information regarding the safety and efficacy of specific direct oral anticoagulants (DOAC) in the treatment of cerebral sinus and venous thrombosis (CSVT) is…”
Get full text

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Michelis, Regina, Tadmor, Tamar, Barhoum, Masad, Shehadeh, Mona, Shvidel, Lev, Aviv, Ariel, Stemer, Galia, Dally, Najib, Rahimi-Levene, Naomi, Yuklea, Mona, Braester, Andrei

“…Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the Western world. The therapeutic approach to CLL includes chemotherapeutic regimens…”
Get full text

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K by Mian, Afsar Ali, Haberbosch, Isabella, Khamaisie, Hazem, Agbarya, Abed, Pietsch, Larissa, Eshel, Elizabeh, Najib, Dally, Chiriches, Claudia, Ottmann, Oliver Gerhard, Hantschel, Oliver, Biondi, Ricardo M., Ruthardt, Martin, Mahajna, Jamal

“…Resistance remains the major clinical challenge for the therapy of Philadelphia chromosome–positive (Ph+) leukemia. With the exception of ponatinib, all…”
Get full text

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis by Avivi, Irit, Perry, Chava, Segman, Yafit, Amit, Odelia, Bar-On, Yaeli, Katz, Ofrat Beyer, Gold, Ronit, Ribakovsky, Elena, Avigdor, Abraham, Vainstein, Vladimir, Goldschmidt, Neta, Ringelstein-Harlev, Shimrit, Horowitz, Netanel A., Gutwein, Odit, Gurion, Ronit, Itchaki, Gilad, Abadi, Uri, Nemets, Anatoly, Sofer, Orit, Vezker, Miri, Tadmor, Tamar, Dally, Najib, Filanovsky, Kalman, Leiba, Merav, Sarid, Nadav, Benyamini, Noam, Luttwak, Efrat, Herishanu, Yair, Ram, Ron

“…Polatuzumab (Pola)-based regimens and chimeric antigen receptor T (CAR T) cells provide superior outcome compared to conventional chemoimmunotherapy in…”
Get full text

A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain by Tadmor, Tamar, Braester, Andrei, Najib, Dally, Aviv, Ariel, Herishanu, Yair, Yuklea, Mona, Shvidel, Lev, Rahimi‐Levene, Naomi, Ruchlemer, Rosa, Arad, Ariela, Fogl, Claudia, Henig, Clara, Barak, Mira, Magal, Lee, Polliack, Aaron, Townsend, Kelly

“…Background Chronic lymphocytic leukemia (CLL) is frequently accompanied by immune dysregulation. Aims In this multicenter prospective study, we investigated…”
Get full text

Clinical Significance and Outcome in Patients with Asymptomatic Versus Symptomatic Subsegmental Pulmonary Embolism by Rodríguez-Cobo, Ana, Fernández-Capitán, Carmen, Tung-Chen, Yale, Salgueiro-Origlia, Giorgina, Ballaz, Aitor, Bortoluzzi, Cristiano, Sarlon-Bartoli, Gabrielle, Pesce, Maria Lourdes, Najib, Dally, Monreal, Manuel, The Riete Investigators

“…The clinical significance and optimal therapy of patients with subsegmental pulmonary embolism (SSPE) remain controversial. We used the data in the RIETE…”
Get full text

P651: REAL‐WORLD EFFECTIVENESS OF VENETOCLAX‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY by Herishanu, Yair, Goldschmidt, Neta, Itchaki, Gilad, Bronstein, Yotam, Levi, Itai, Aviv, Ariel, Fineman, Riva, Dally, Najib, Tadmor, Tamar, Ronson, Aaron, Abadi, Uri, Shvidel, Levi, Stemer, Galia, Kay, Sigi, Glait Santar, Chen, Barak, Moran, Rivlin, Noa, Kaminsky, Natalie, Cohen, Raanan, Ofek, Keren, Berelovich, Jenia, Grunspan, Moshe, Benjamini, Ohad

Get full text

Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers by Levinas, Tatyana, Eshel, Elizabeth, Sharabi-Nov, Adi, Marmur, Alon, Dally, Najib

“…Chest pain is one of the most common complaints seen in emergency departments (ED), up to 5–8 % of all ED visits. About 50–60 % of chest pain patients…”
Get full text

Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia—a single center experience in 34 patients by Dally, Najib, Hoffman, Ron, Haddad, Nuhad, Sarig, Galit, Rowe, Jacob M., Brenner, Benjamin

“…In this retrospective study, the hemorrhagic and thrombotic events are reported at presentation and during induction in 34 consecutive acute promyelocytic…”
Get full text

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination by Herishanu, Yair, Rahav, Galia, Levi, Shai, Braester, Andrei, Itchaki, Gilad, Bairey, Osnat, Dally, Najib, Shvidel, Lev, Ziv-Baran, Tomer, Polliack, Aaron, Tadmor, Tamar, Benjamini, Ohad

“…Patients with chronic lymphocytic leukemia (CLL) have an impaired antibody response to coronavirus disease 2019 (COVID-19) vaccination. Here, we evaluated the…”
Get full text

The Impact of BMI on the Outcome of Lymphoma Treatment by Dally, Najib, Saleem, Jackie, Tarabeh, Khalil, Kashlikov, Marat

Get full text

Insights into direct anticoagulants by Saad, Elias, Dally, Najib

“…For the past five decades, vitamin K antagonists (VKA) have been the only class of oral anticoagulants available for treating or preventing venous and arterial…”
Get full text

A New Take on a Resource-Based Model of Quality of Life in Hemato-Oncological Patients: Demographic, Personal, and Social Factors by Zysberg, Leehu, Hai, Sharon, Dally, Najib

“…This study tests a new comprehensive model accounting for the role of demographic, personal, and social factors in quality of life (QOL) among a sample of…”
Get full text

Can Blood Inflammatory Markers Identify Pregnant Women with Preeclampsia? Still a Controversial Issue by Braester, Andrei, Bilyk, Artyom, Suriu, Celia, Akria, Luiza, Dally, Najib, Barhoum, Masad

“…Preeclampsia is a unique vascular disease during pregnancy that generally appears after 20 of weeks gestation or until 6 weeks after delivery. Left…”
Get full text

Ethnic disparities in presentation but not outcome in multiple myeloma patients: a multicenter retrospective study in Northern Israel by Dally, Najib, Baranes, Myriam, Akria, Luiza, Kashlikov, Marat, Tarabia, Khalil, Sharabi-Nov, Adi, Suriu, Celia, Braester, Andrei

“…Several studies showed ethnic disparities in multiple myeloma (MM) incidence and prognosis. In order to compare prognosis and overall survival between…”
Get full text

Can an Anemic Patient Be a Partner to Treatment Decision-Making? by Braester, Andrei, Suriu, Celia, Akria, Luiza, Zarfati, Moran, Dally, Najib, Barhoum, Masad

Get full text